AIG
AKRO

American International Group’s Akero Therapeutics AKRO Stock Holding History

American International Group’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,326
Closed -$766K – 94
2024
Q1 		$766K Buy
30,326
+4,812
+19% +$116K ﹤0.01% 1439
2023
Q4 		$596K Sell
25,514
-103
-0.4% -$2.03K ﹤0.01% 1564
2023
Q3 		$1.3M Buy
25,617
+3,993
+18% +$186K 0.01% 1110
2023
Q2 		$1.01M Buy
21,624
+4,799
+29% +$220K 0.01% 1248
2023
Q1 		$644K Buy
16,825
+334
+2% +$14.9K ﹤0.01% 1455
2022
Q4 		$904K Buy
16,491
+3,193
+24% +$137K 0.01% 1263
2022
Q3 		$453K Buy
13,298
+188
+1% +$2.88K ﹤0.01% 1639
2022
Q2 		$124K Buy
13,110
+345
+3% +$3.6K ﹤0.01% 2455
2022
Q1 		$181K Sell
12,765
-898
-7% -$15.7K ﹤0.01% 2296
2021
Q4 		$289K Sell
13,663
-409
-3% -$9.07K ﹤0.01% 2142
2021
Q3 		$315K Sell
14,072
-334
-2% -$7.56K ﹤0.01% 2142
2021
Q2 		$357 Buy
14,406
+6,515
+83% +$183K ﹤0.01% 2140
2021
Q1 		$229 Buy
7,891
+21
+0.3% +$636 ﹤0.01% 2296
2020
Q4 		$203 Sell
7,870
-226
-3% -$6.29K ﹤0.01% 2281
2020
Q3 		$249K Buy
8,096
+1,255
+18% +$43.9K ﹤0.01% 2000
2020
Q2 		$170K Buy
6,841
+1,885
+38% +$43.1K ﹤0.01% 2215
2020
Q1 		$105K Buy
4,956
+1,894
+62% +$40.6K ﹤0.01% 2276
2019
Q4 		$68K Buy
3,062
+44
+1% +$910 ﹤0.01% 2791
2019
Q3 		$69K Buy
+3,018
New +$70.2K ﹤0.01% 2791

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

American International Group's AKRO Position: Q2 2024 in Review

American International Group sold out of Akero Therapeutics (AKRO) in Q2 2024, closing a stake of 30,326 shares — an estimated $766K sold.

American International Group first reported a position in AKRO in Q3 2019 and held it in 19 quarters. The position peaked at $1.3M in Q3 2023. 153 funds tracked by Wall St. Rank hold AKRO as of Q2 2024.

  • American International Group reported no remaining Akero Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 30,326 Akero Therapeutics shares in Q2 2024, an estimated $766K.
  • American International Group first reported a position in Akero Therapeutics in Q3 2019 and held it in 19 quarters.
  • American International Group's Akero Therapeutics position peaked at $1.3M in Q3 2023.
  • 153 funds tracked by Wall St. Rank held Akero Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.